← Back to Search
Hyaluronic Acid Nanoparticles For Active Targeting Atherosclerosis.
G. Lee, J. Kim, K. Choi, H. Yoon, K. Kim, I. C. Kwon, K. Choi, Byung-Heon Lee, J. Park, I. Kim
Published 2015 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
For the effective diagnosis and therapy of atherosclerosis, there is a pressing need to develop the carrier which can specifically deliver the agents to the pathological site. Since the representative hallmark of atherosclerosis in its pathogenic process is the over-expression of the receptors for hyaluronic acid (HA) such as stabilin-2 and CD44, we herein investigated the potential of HA nanoparticles (HA-NPs) as the carrier for active targeting atherosclerosis. From in vitro cellular uptake tests, it was revealed that HA-NPs were selectively taken up by the cells over-expressing stabilin-2 or CD44. On the other hand, the cellular uptake of HA-NPs was drastically reduced when the cells were pre-treated with excess amount of free HA, implying that HA-NPs were taken up by the receptor-mediated endocytosis. Following systemic administration of Cy5.5-labeled NPs into the ApoE-deficient mice as the animal model, the atherosclerotic legion was assessed at 24 post-injection by using the optical imaging system. Interestingly, the fluorescent signal of the atherosclerotic lesion by HA-NPs was much stronger than that of the normal aorta. Three dimensional z-stack images of an atherosclerotic plaque indicated the even distribution of HA-NPs in the atherosclerotic legion. It was demonstrated by immunohistochemistry that HA-NPs were co-localized with the HA receptors including stabilin-2 and CD44. In addition, the amount of HA-NPs, accumulated in the atherosclerotic lesion, was much higher than that of HGC-NPs, known to reach the atherosclerotic lesion by the passive targeting mechanism. Overall, it was evident that HA-NPs could effectively reach the atherosclerotic lesion via the active targeting mechanism after systemic administration, implying their high potential as the carrier for diagnosis and therapy of atherosclerosis.
This paper references
Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
H. Han (2013)
Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
K. Choi (2011)
Augmented levels of CD44 in macrophages from atherosclerotic subjects: a possible IL-6-CD44 feedback loop?
Daniel A. Hägg (2007)
Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells.
A. Krettek (2004)
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
K. Choi (2010)
Hyaluronan: Preparation, Structure, Properties, and Applications.
Lubomír Lapcík L Jr and (1998)
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118: 1172e82
PW Serruys (2008)
Photo - cross - linked hyaluronic acid nanoparticles with improved stability for in vivo tumortargeted drug delivery
HY Yoon (2013)
Programmable nanoparticle functionalization for in vivo targeting
Hua Pan (2013)
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
K. Kim (2010)
Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.
G. Lee (2011)
A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Kyeongsoon Park (2008)
Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
K. Choi (2012)
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
R. Klingenberg (2009)
Augmented levels of CD 44 in macrophages from atherosclerotic subjects : a possible IL - 6 e CD 44 feedback loop ?
B Fagerberg (2007)
Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.
H. Yoon (2013)
Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis.
P. Bot (2008)
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
Virginia M Platt (2008)
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
M. Lobatto (2011)
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.
R. Virmani (2000)
Form to function: current and future roles for atherosclerosis imaging in drug development
A. Lindsay (2008)
Anatomic features in victims of sudden coronary death. Coronary artery pathology.
M. Davies (1992)
Gold nanoparticle-conjugated anti-oxidized low-density lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkers.
Helmut Hinterwirth (2013)
Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting.
H. Yoon (2013)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
Atherosclerosis: current pathogenesis and therapeutic options
C. Weber (2011)
Inflammation in Atherosclerosis
P. Libby (2012)
Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.
M. Kamat (2010)
Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Jae Hyung Park (2006)
Angiogenesis: an organizing principle for drug discovery?
J. Folkman (2007)
Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.
K. Choi (2012)
PET/CT Imaging of Chemokine Receptor CCR5 in Vascular Injury Model Using Targeted Nanoparticle
H. Luehmann (2014)
Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.
Dong Gil You (2014)
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
P. Serruys (2008)
Nanotechnology: Carrying drugs
K. Bourzac (2012)
Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor
S. Park (2008)
Preparation, structure, properties and applications of gel-spun ultrastrong polyethylene fibers
D. C. Prevorsek (1995)
Hyaluronan: Preparation, Structure, Properties, and Applications
Lubomic Lapcik (1999)
Treating metastatic cancer with nanotechnology
Avi Schroeder (2011)
Structure and function of HDL mimetics.
M. Navab (2010)
Molecular, cellular and functional imaging of atherothrombosis
R. Choudhury (2004)
This paper is referenced by
Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating
Seungmin Lee (2015)
Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.
W. He (2019)
Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
Vahid Taghipour-Sabzevar (2019)
Scalable and cleavable polysaccharide nanocarriers for the delivery of chemotherapy drugs.
H. Wang (2018)
Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis.
Shuihua Zhang (2020)
Hyaluronic acid functionalized nitrogen-doped carbon quantum dots for targeted specific bioimaging
Mingsuo Zhang (2016)
Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases
Yudi Deng (2019)
Polysaccharide-based Nanoparticles for Theranostic Nanomedicine Special Issue: Non-Antigenic Regulators of Targeting for Imaging and Therapy
Magdalena Swierczewska (2017)
Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.
J. Bizeau (2017)
Biodegradable Polysaccharides for Controlled Drug Delivery.
Janarthanan Pushpamalar (2016)
Hierarchically built hyaluronan nano‐platelets have symmetrical hexagonal shape, flattened surfaces and controlled size
Raul Diaz‐Salmeron (2019)
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery.
F. Carton (2019)
Tumor-Targeting Glycol Chitosan Nanoparticles for Image-Guided Surgery of Rabbit Orthotopic VX2 Lung Cancer
Kyeong Cheol On (2020)
Recent Advances in Managing Atherosclerosis via Nanomedicine.
Cecilia K. W. Chan (2018)
Recent progress in the detection and treatment of atherosclerosis by nanoparticles
L. Chen (2020)
Hyaluronic Acid-Based Activatable Nanomaterials for Stimuli-Responsive Imaging and Therapeutics: Beyond CD44-Mediated Drug Delivery.
Ki Young Choi (2019)
Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques.
Xiao Li (2016)
Active Nano-targeting of Macrophages.
Nataša Gašpar (2019)
Development and characterization of crosslinked hyaluronic acid polymeric films for use in coating processes.
Débora Sgorla (2016)
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
T. Beldman (2017)
Desirable PEGylation for improving tumor selectivity of hyaluronic acid-based nanoparticles via low hepatic captured, long circulation times and CD44 receptor-mediated tumor targeting.
Chao Teng (2019)
Hybrid gels by conjugation of hyaluronic acid with poly(itaconic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5)undecane) copolymers.
A. Chiriac (2017)
Magnetic iron oxide nanoparticles as novel and efficient tools for atherosclerosis diagnosis.
M. G. Montiel Schneider (2017)
Marine Polysaccharide‐Based Nanomaterials
Sudip Mondal (2020)
Hyaluronic acid mediated biomineralization of multifunctional ceria nanocomposites as ROS scavengers and tumor photodynamic therapy agents
Yiping Zeng (2019)
Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
Y. Zhao (2017)
Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation
Meng-dan Zhao (2016)
Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
Y. Xia (2020)
Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis.
Roun Heo (2017)
Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases
N. V. Rao (2020)
Investigating MTX-Loaded magnetic nanocomposite particles for treatment of rheumatoid arthritis
A. Usta (2020)
Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systems.
E. Csapó (2018)See more